Who can join? People 21 years or older having the TAVR procedure and at high risk of blood flow blockage can join. Before participating, they’ll be screened through tests and questionnaires about their health and quality of life. The study includes a hospital visit for TAVR, followed by check-ups after 30 and 90 days.
- Study Length: Lasts about 3 months with check-ups.
- Visits Needed: Hospital visit for the procedure, and follow-ups in 30 and 90 days.
- Risks: The procedure can be risky, but the new device aims to make it safer.